BCL2 and hypopharyngeal carcinoma: It is widely thought that c-Jun might function similarly in hypopharyngeal carcinoma as in nasopharyngeal carcinoma [29], where it upregulates Bcl-2 to inhibit apoptosis and confer Chemoresistance.